subscribeSubscribe
price-trendAsk Us
Getting patented meds on NLEM list an uphill battle says committee member

Getting patented meds on NLEM list an uphill battle says committee member
Teena Thacker ECONOMIC TIMES
15 Sep 2022
Share Share
Diabetes, patented TB, HIV drugs enter essential list

Diabetes, patented TB, HIV drugs enter essential list
Teena Thacker ECONOMICTIMES
13 Sep 2022
Share Share
Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet

Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet
JIHO
06 Oct 2021
Share Share
Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary

Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary
PRESS RELEASE
25 May 2020
Share Share
Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB

Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB
PHARMA BIZ
08 Feb 2019
Share Share
Johnson and Johnson asked to cut down price of new TB drug

Johnson and Johnson asked to cut down price of new TB drug
Divya Rajagopal ECONOMIC TIMES
23 Oct 2018
Share Share
J&J, Macleods in talks for licence deal of tuberculosis drug

J&J, Macleods in talks for licence deal of tuberculosis drug
DIVYA RAJAGOPAL ECONOMIC TIMES
12 Mar 2018
Share Share
WHO invites applications from drug companies pre-qualification of MDR TB drugs

WHO invites applications from drug companies pre-qualification of MDR TB drugs
DIVYA RAJAGOPAL ECONOMIC TIMES
09 Mar 2018
Share Share